Effects of Synthetic Cannabinoid MMB-2201 on Brain Angiogenesis
Author Information
Author(s): AL-Eitan Laith Naser, Alahmad Saif Zuhair, Ajeen Sufyan Ali, Altawil Ahmad Younis, Khair Iliya Yacoub, Kharmah Hana Salah Abu, Alghamdi Mansour Abdullah
Primary Institution: Jordan University of Science and Technology
Hypothesis
The study aims to examine the effects of the synthetic cannabinoid MMB-2201 on brain angiogenesis in vitro.
Conclusion
MMB-2201 significantly enhances the proliferation, migration, and angiogenic capability of human cerebral microvascular endothelial cells.
Supporting Evidence
- MMB-2201 increased metabolic activity in endothelial cells.
- MMB-2201 promoted migration of endothelial cells.
- MMB-2201 enhanced the formation of tube-like structures in vitro.
- VEGF, ANG-1, and ANG-2 levels were significantly upregulated following MMB-2201 treatment.
Takeaway
This study shows that a synthetic cannabinoid can help brain cells grow new blood vessels, which is important for healing and recovery.
Methodology
Human cerebral microvascular endothelial cells were treated with MMB-2201, and their metabolic activity, migration, and tube formation were assessed using various assays.
Limitations
The study's findings may not fully translate to in vivo systems due to the controlled in vitro conditions.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website